We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Outlines Methods for Transferring Product Approvals Before Brexit
EMA Outlines Methods for Transferring Product Approvals Before Brexit
The European Medicines Agency published new, practical guidance for marketing authorization holders in navigating the UK’s 2019 departure from the European Union — including the procedures for classifying any Brexit-related impacts on pharmaceutical manufacturing.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor